Ropeginterferon alfa-2b-njft treatment in essential thrombocythemia across different driver mutations: results from a North American, single-arm, multicentre study (EXCEED-ET)
Document Type
Article
Publication Title
The Lancet Regional Health Americas
DOI
https://doi.org/10.1016/j.lana.2026.101529
Publication Date
6-10-2026
Recommended Citation
Li, Zhuoyan, "Ropeginterferon alfa-2b-njft treatment in essential thrombocythemia across different driver mutations: results from a North American, single-arm, multicentre study (EXCEED-ET)" (2026). Hematology-Oncology. 46.
https://scholarlycommons.gbmc.org/hem_onc/46
COinS